SS Innovations International (NASDAQ: SSII) announced that its subsidiary, the SS International Centre for Robotics Surgery (“SSICRS”), has graduated the inaugural class of its Cardiac Robotic Surgery Training program. The five-day course brought together 33 participants from seven countries and 16 international faculty members for classroom instruction, live surgical demonstrations and hands-on training using the company’s SSi Mantra surgical robotic system.
SS Innovations International (NASDAQ: SSII) has engaged IBN to support its corporate communications strategy as the company continues to advance its portfolio of surgical robotic technologies. SS Innovations’ product lineup is led by its proprietary SSi Mantra surgical robotic system, which has been used in more than 11,700 procedures worldwide and is complemented by the SSi Mudra robotic instruments, SSi MantrAsana tele-surgeon console and SSi Maya mixed-reality platform.
SS Innovations International Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards (“SRIA”), receiving recognition from the industry organization for its work in developing and commercializing robotic surgery technology ( https://ibn.fm/lDfv9 ).
SS Innovations International (NASDAQ: SSII) announced it has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, which recognizes a company demonstrating excellence in innovation, commercial success, industry leadership and positive societal impact. The company said the award reflects growing adoption of its SSi Mantra surgical robotic system, which it believes is gaining traction for its advanced technology, user-friendly design, training capabilities and cost efficiency.
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies to aid in cardiac and other surgeries, including telesurgeries, reported record first-quarter 2026 financial results, highlighting accelerating commercial adoption of its SSi Mantra surgical robotic platform as the company continues expanding internationally and pursuing regulatory approvals in major healthcare markets.
SS Innovations (NASDAQ: SSII) announced the successful completion of what it said is the world’s longest-distance robotic telesurgery, with a robot-assisted cardiac procedure performed across approximately 12,500 miles (20,000 kilometers) of fiber network distance between Guyana and India using the company’s SSi Mantra surgical robotic system. The procedure was conducted remotely by CEO and cardiac surgeon Dr. Sudhir Srivastava from Guyana, while the patient-side robotic system operated in India, functioning with network latency of approximately 290-300 milliseconds.
SS Innovations (NASDAQ: SSII) announced the successful completion of what it said is the world’s longest-distance robotic telesurgery, with a robot-assisted cardiac procedure performed across approximately 12,500 miles (20,000 kilometers) of fiber network distance between Guyana and India using the company’s SSi Mantra surgical robotic system. The procedure was conducted remotely by CEO and cardiac surgeon Dr. Sudhir Srivastava from Guyana, while the patient-side robotic system operated in India, functioning with network latency of approximately 290-300 milliseconds.
